Assessing Treatment Response and Prognosis by Serum and Tissue Metabolomics in Breast Cancer Patients
2019 · Journal of Proteome Research · 58 citations
https://doi.org/10.1021/acs.jproteome.9b00316
H
Hedda von der Lippe Gythfeldt
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
27
Papers
216
Citations
6
h-index
6
i10-index
Hedda von der Lippe Gythfeldt is an academic researcher from Oslo University Hospital. The author has contributed to research in topics: Cancer Genomics and Diagnostics & Breast Cancer Treatment Studies & Cancer Treatment and Pharmacology. The author has an h-index of 6, co-authored 23 publications.
ORCID: 0000-0002-1870-6402Papers by this author
worksImproving public cancer care by implementing precision medicine in Norway: IMPRESS-Norway
2022 · Journal of Translational Medicine · 25 citations
https://doi.org/10.1186/s12967-022-03432-5
Immune phenotype of tumor microenvironment predicts response to bevacizumab in neoadjuvant treatment of <scp>ER</scp>‐positive breast cancer
2020 · International Journal of Cancer · 18 citations
https://doi.org/10.1002/ijc.33108
Additional file 3: of Time series analysis of neoadjuvant chemotherapy and bevacizumab-treated breast carcinomas reveals a systemic shift in genomic aberrations
2018 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.7404911
Additional file 5: of Time series analysis of neoadjuvant chemotherapy and bevacizumab-treated breast carcinomas reveals a systemic shift in genomic aberrations
2018 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.7404953
Additional file 6: of Time series analysis of neoadjuvant chemotherapy and bevacizumab-treated breast carcinomas reveals a systemic shift in genomic aberrations
2018 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.7404974
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat